Details of the Drug

General Information of Drug (ID: DMS6QGO)

Drug Name

ALS-L1023

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01872182) Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome. U.S. National Institutes of Health.